PA
PBI icon

PharVision Advisers’s Pitney Bowes PBI Stock Holding History

PharVision Advisers’s Portfolio PBI Stock Details PBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,771
Closed -$128K – 760
2025
Q2 		$128K Buy
+11,771
New +$111K 0.18% 240
2025
Q1 		– Sell
-14,793
Closed -$107K – 458
2024
Q4 		$107K Buy
+14,793
New +$110K 0.09% 370

Other funds holding PBI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Hestia Capital Management Cranberry Township, Pennsylvania $111M AUM 21.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PC
Permit Capital West Conshohocken, Pennsylvania $294M AUM 27.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PharVision Advisers's PBI Position: Q3 2025 in Review

PharVision Advisers sold out of Pitney Bowes (PBI) in Q3 2025, closing a stake of 11,771 shares — an estimated $128K sold.

PharVision Advisers first reported a position in PBI in Q4 2024 and held it in 2 quarters. The position peaked at $128K in Q2 2025. 320 funds tracked by Wall St. Rank hold PBI as of Q3 2025.

  • PharVision Advisers reported no remaining Pitney Bowes position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 11,771 Pitney Bowes shares in Q3 2025, an estimated $128K.
  • PharVision Advisers first reported a position in Pitney Bowes in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Pitney Bowes position peaked at $128K in Q2 2025.
  • 320 funds tracked by Wall St. Rank held Pitney Bowes as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.